TABLE 2.

Changes in Outcome Variables (from Baseline to Follow-Up) Between Study Groups^*†

	Type 2 Diabetes		New vs. No Diabetes Groups(mean change [95% CI]; P)
	No (mean change [95% CI]; P)	New†(mean change [95% CI]; P)
Body weight (kg)	0.69 (0.43–0.96); <0.0001	–0.67 (–1.21 to –0.14); 0.014	–1.38 (–1.85 to –0.89); <0.0001
Sitting (h/day)	–0.55 (–0.70 to –0.42); <0.0001	–0.36 (–0.61 to –0.10); 0.006	0.19 (–0.03 to 0.42); 0.101
Walking (min/week)	2.08 (–8.63 to 12.79); 0.703	12.87 (–8.14 to 33.88); 0.228	10.79 (–7.82 to 29.39); 0.256
MVPA (min/week)	10.44 (–20.56 to 41.44); 0.509	–2.34 (–64.01 to 59.33); 0.941	–11.51 (–66.36 to 43.34); 0.680
Fruit consumption (servings/day)	–0.14 (–0.18 to –0.10); <0.0001	–0.08 (–0.16 to –0.003); 0.043	0.05 (–0.02 to 0.12); 0.148
Vegetable consumption (servings/day)	–0.45 (–0.54 to –0.36); <0.0001	–0.24 (–0.42 to –0.09); 0.011	0.21 (0.05–0.38); 0.011
Cigarettes smoked (n/day)‡	–0.41 (–1.41 to 0.61); 0.469	–2.23 (–4.62 to 0.17); 0.069	–1.82 (–4.03 to 0.39); 0.107
	No (%)	New (%)	New vs. No Diabetes Groups (odds of quitting [95% CI]; P)
Cessation of smoking§	30.8	50.0	2.71 (1.59–4.63); 0.0002

^*Mean adjusted for baseline and demographic characteristics.

^†Incident or new cases (participants who did not report type 2 diabetes at the baseline survey but did report type 2 diabetes at the follow-up survey).

^‡Among participants who reported smoking at both the baseline and follow-up surveys.

^§Among participants who reported smoking at the baseline survey.